<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39399343</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2314-6141</ISSN><JournalIssue CitedMedium="Internet"><Volume>2024</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>BioMed research international</Title><ISOAbbreviation>Biomed Res Int</ISOAbbreviation></Journal><ArticleTitle>Outbreak Response to Circulating Vaccine-Derived Poliovirus in Three Northern Regions of Ghana, 2019.</ArticleTitle><Pagination><StartPage>5515777</StartPage><MedlinePgn>5515777</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5515777</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2024/5515777</ELocationID><Abstract><AbstractText><b>Background:</b> Circulating Vaccine-Derived Poliovirus Type 2 (cVDPV2) was isolated in sewage and later in stool samples from children with acute flaccid paralysis (AFP) in northern Ghana. <b>Method:</b> A multidisciplinary and multisectoral team investigated this outbreak and reported on epidemiological and laboratory investigations. Sewage/wastewater samples were collected from the environment, while stool samples were collected from AFP/contact children under 5 years of age. The samples were processed for virus isolation, and positive isolates were sequenced. We also conducted a descriptive investigation involving a review of records, active case search, and Monovalent Oral Polio Vaccine 2 campaigns. Additionally, we interviewed caregivers about the vaccination status of their children, as well as their knowledge on polio prevention. Water quality, sanitation, hygiene practices, and health-seeking behaviours were also assessed. <b>Results:</b> A total of 18 cVDPV2 were confirmed in the three regions of Ghana during the outbreak in 2019-2020. All strains were genetically linked to a Nigerian cVDPV2 strain NIE-KWS-KSB-18-006HC29 that circulated in 2018. Evaluation of the surveillance system shows that officers have good knowledge of AFP and know how to collect samples, package them, and ship them to the laboratory. Few communities had access to potable water. Open defecation was common, and the water supply, sanitation, and hygiene practices of the communities were poor. <b>Conclusion:</b> The cVDPV2 outbreak represents the first time cVDPV2 has circulated in the country since Ghana embarked on the polio eradication program in 1996. However, with quality mOPV2 mop-up campaigns, a nationwide IPV catch-up campaign coupled with enhanced surveillance measures, transmission was interrupted.</AbstractText><CopyrightInformation>Copyright © 2024 John Kofi Odoom et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Odoom</LastName><ForeName>John Kofi</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Virology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dzotse</LastName><ForeName>Emmanuel Kofi</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Disease Surveillance Department, Ghana Health Service, Ministry of Health, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nii-Trebi</LastName><ForeName>Nicholas Israel</ForeName><Initials>NI</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Opare</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Public Health and Reference Laboratory, Ghana Health Service, Ministry of Health, Korle-Bu, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akyereko</LastName><ForeName>Ernest</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Disease Surveillance Department, Ghana Health Service, Ministry of Health, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attiku</LastName><ForeName>Keren</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Virology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duker</LastName><ForeName>Ewurabena Oduma</ForeName><Initials>EO</Initials><AffiliationInfo><Affiliation>Department of Virology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eshun</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Virology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boahene</LastName><ForeName>Bismarck Banahene</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Department of Virology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gberbi</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Virology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Houphouet</LastName><ForeName>Ekua Essumanma</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>World Health Organization, Country Office, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diamenu</LastName><ForeName>Stanley</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>World Health Organization, Country Office, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adjabeng</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>World Health Organization, Country Office, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asamoah-Frimpong</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>African Field Epidemiology Network, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ameme</LastName><ForeName>Donne</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Ghana Field Epidemiology and Laboratory Training Program, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Opare</LastName><ForeName>Joseph Kojo Larbi</ForeName><Initials>JKL</Initials><AffiliationInfo><Affiliation>Ghana Health Service, Private Mail Bag, Ministries, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obodai</LastName><ForeName>Evangeline</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5358-5688</Identifier><AffiliationInfo><Affiliation>Department of Virology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biomed Res Int</MedlineTA><NlmUniqueID>101600173</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012722">Sewage</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012722" MajorTopicYN="Y">Sewage</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute flaccid paralysis (AFP)</Keyword><Keyword MajorTopicYN="N">circulating vaccine-derived poliovirus (cVDPV)</Keyword><Keyword MajorTopicYN="N">environmental surveillance</Keyword><Keyword MajorTopicYN="N">northern Ghana</Keyword><Keyword MajorTopicYN="N">outbreak investigation</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>7</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39399343</ArticleId><ArticleId IdType="pmc">PMC11469924</ArticleId><ArticleId IdType="doi">10.1155/2024/5515777</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khan F., Datta S. D., Quddus A., et al. Progress toward polio eradication-worldwide, January 2016-March 2018. MMWR. Morbidity and Mortality Weekly Report . 2018;67(18):524–528. doi: 10.15585/mmwr.mm6718a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6718a4</ArticleId><ArticleId IdType="pmc">PMC5944975</ArticleId><ArticleId IdType="pubmed">29746452</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew O., Sutter R. W., de Gourville E. M., Dowdle W. R., Pallansch M. A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annual Review of Microbiology . 2005;59:587–635.</Citation><ArticleIdList><ArticleId IdType="pubmed">16153180</ArticleId></ArticleIdList></Reference><Reference><Citation>Minor P. D., Almond J. Molecular Biology of Picornavirus . John Wiley &amp; Sons, Inc.; 2014. Poliovirus vaccines: molecular biology and immune response; pp. 381–390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/9781555817916.ch30</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutter R. W., Kew O. M., Cochi S. L. Vaccines (Fifth Edition) Elsevier Inc.; 2008. Chapter 26 - Poliovirus vaccine-live; pp. 631–685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/b978-1-4160-3611-1.50030-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C. F., Naguib T., Yang S. J., et al. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. Journal of Virology . 2003;77(15):8366–8377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC165252</ArticleId><ArticleId IdType="pubmed">12857906</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew O., Morris-Glasgow V., Landaverde M., et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science . 2002;296(5566):356–359.</Citation><ArticleIdList><ArticleId IdType="pubmed">11896235</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H., Thorley B., Paladin F. J., et al. Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. Journal of Virology . 2004;78(24):13512–13521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC533948</ArticleId><ArticleId IdType="pubmed">15564462</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC) Update on vaccine-derived polioviruses--worldwide, January 2006-August 2007. MMWR. Morbidity and Mortality Weekly Report . 2007;56:996–1001.</Citation><ArticleIdList><ArticleId IdType="pubmed">17898693</ArticleId></ArticleIdList></Reference><Reference><Citation>Estívariz C. F., Watkins M. A., Handoko D., et al. A large vaccine-derived poliovirus outbreak on Madura Island--Indonesia, 2005. The Journal of Infectious Diseases . 2008;197(3):347–354. doi: 10.1086/525049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/525049</ArticleId><ArticleId IdType="pubmed">18199031</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang X., Zhang Y., Xu W., et al. An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China. The Journal of Infectious Diseases . 2006;194(5):545–551. doi: 10.1086/506359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/506359</ArticleId><ArticleId IdType="pubmed">16897650</ArticleId></ArticleIdList></Reference><Reference><Citation>Kline A., Dean K., Kossik A. L., et al. Persistence of poliovirus types 2 and 3 in waste-impacted water and sediment. PLoS One . 2022;17(1, article e0262761) doi: 10.1371/journal.pone.0262761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0262761</ArticleId><ArticleId IdType="pmc">PMC8791527</ArticleId><ArticleId IdType="pubmed">35081146</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovi T., Cantell K., Huovilainen A., et al. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. The Lancet . 1986;1(8495):1427–1432. doi: 10.1016/s0140-6736(86)91566-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(86)91566-7</ArticleId><ArticleId IdType="pubmed">2872526</ArticleId></ArticleIdList></Reference><Reference><Citation>Manor Y., Handsher R., Halmut T., et al. Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority. Journal of Clinical Microbiology . 1999;37(6):1670–1675. doi: 10.1128/JCM.37.6.1670-1675.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.37.6.1670-1675.1999</ArticleId><ArticleId IdType="pmc">PMC84919</ArticleId><ArticleId IdType="pubmed">10325305</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovi T., Stenvik M., Partanen H., Kangas A. Poliovirus surveillance by examining sewage specimens. Quantitative recovery of virus after introduction into sewerage at remote upstream location. Epidemiology and Infection . 2001;127(1):101–106. doi: 10.1017/S0950268801005787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268801005787</ArticleId><ArticleId IdType="pmc">PMC2869716</ArticleId><ArticleId IdType="pubmed">11561962</ArticleId></ArticleIdList></Reference><Reference><Citation>Odoom J. K., Obodai E., Diamenu S., et al. Environmental surveillance for poliovirus in Greater Accra and eastern regions of Ghana-2016. Virology: Current Research . 2017;1(1, article 1000101)</Citation></Reference><Reference><Citation>Ghana Statistical Service and Central Bureau of Statistics. 2010 Population and housing census: summary report of final results . Ghana Statistical Service and Central Bureau of Statistics; 2012.</Citation></Reference><Reference><Citation>Ghana Health Service. The health sector in Ghana; facts and figures . Ghana Health Service; 2015.</Citation></Reference><Reference><Citation>World Health Organization. Polio laboratory manual . World Health Organization; 2004.</Citation></Reference><Reference><Citation>Kilpatrick D. R., Nottay B., Yang C. F., et al. Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. Journal of Clinical Microbiology . 1996;34(12):2990–2996. doi: 10.1128/jcm.34.12.2990-2996.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.34.12.2990-2996.1996</ArticleId><ArticleId IdType="pmc">PMC229447</ArticleId><ArticleId IdType="pubmed">8940436</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilpatrick D. R., Nottay B., Yang C. F., et al. Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. Journal of Clinical Microbiology . 1998;36(2):352–357. doi: 10.1128/JCM.36.2.352-357.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.36.2.352-357.1998</ArticleId><ArticleId IdType="pmc">PMC104541</ArticleId><ArticleId IdType="pubmed">9466740</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura K., Dudley J., Nei M., Kumar S. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Molecular Biology and Evolution . 2007;24(8):1596–1599. doi: 10.1093/molbev/msm092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msm092</ArticleId><ArticleId IdType="pubmed">17488738</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson J. D., Gibson T. J., Plewniak F., Jeanmougin F., Higgins D. G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Research . 1997;25(24):4876–4882. doi: 10.1093/nar/25.24.4876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/25.24.4876</ArticleId><ArticleId IdType="pmc">PMC147148</ArticleId><ArticleId IdType="pubmed">9396791</ArticleId></ArticleIdList></Reference><Reference><Citation>Felsenstein J. PHYLIP: phylogeny inference package. Version 4.0a. 2014.  
 https://jsh.github.io/phylip/main.html
.</Citation></Reference><Reference><Citation>Page R. D. M. TreeView: an application to display phylogenetic trees on personal computers. Computer Applications in the Biosciences . 1996;12(4):357–358. doi: 10.1093/bioinformatics/12.4.357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/12.4.357</ArticleId><ArticleId IdType="pubmed">8902363</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Circulating vaccine-derived poliovirus type 2 – global update. 2019.  
 https://www.who.int/csr/don/06-september-2019-polio-ghana/en/
</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Update on vaccine-derived polioviruses. 2006;55(40):1093–1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">17035927</ArticleId></ArticleIdList></Reference><Reference><Citation>Garon J., Seib K., Orenstein W. A., et al. Polio endgame: the global switch from tOPV to bOPV. Expert Review of Vaccines . 2016;15(6):693–708. doi: 10.1586/14760584.2016.1140041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1140041</ArticleId><ArticleId IdType="pubmed">26751187</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Commission for the Certification of Poliomyelitis Eradication (GCC) 14th Meeting of the global commission for the certification of poliomyelitis eradication (GCC) Bali, Indonesia, 20–21 2015: summary of findings, decisions and recommendations . Geneva, Switzerland: World Health Organization; 2015.</Citation></Reference><Reference><Citation>Koopman J. S., Henry C. J., Park J. H., Eisenberg M. C., Ionides E. L., Eisenberg J. N. Dynamics affecting the risk of silent circulation when oral polio vaccination is stopped. Epidemics . 2017;20:21–36. doi: 10.1016/j.epidem.2017.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2017.02.013</ArticleId><ArticleId IdType="pmc">PMC5608688</ArticleId><ArticleId IdType="pubmed">28283373</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative. The switch from tOPV to bOPV: implementation guidelines. A Handbook for National Decision Makers, Programme Managers, Logisticians, and Consultants . Geneva: World Health Organization; 2016.</Citation></Reference><Reference><Citation>Thompson K. M., Tebbens R. J. D. Modeling the dynamics of oral poliovirus vaccine cessation. The Journal of Infectious Diseases . 2014;210(Supplement_1):S475–S484. doi: 10.1093/infdis/jit845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jit845</ArticleId><ArticleId IdType="pubmed">25316870</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba J., Diop O. M., Iber J., Sutter R. W., Wassilak S. G., Burns C. C. Update on vaccine-derived polioviruses-worldwide, January 2015-May 2016. MMWR. Morbidity and Mortality Weekly Report . 2016;65(30):763–769. doi: 10.15585/mmwr.mm6530a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6530a3</ArticleId><ArticleId IdType="pubmed">27491079</ArticleId></ArticleIdList></Reference><Reference><Citation>Alleman M. M., Jorba J., Greene S. A., et al.  Update on vaccine-derived poliovirus outbreaks — worldwide, July 2019–February 2020. MMWR. Morbidity and Mortality Weekly Report . 2020;69(16):489–495. doi: 10.15585/mmwr.mm6916a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6916a1</ArticleId><ArticleId IdType="pmc">PMC7188410</ArticleId><ArticleId IdType="pubmed">32324719</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba J., Diop O. M., Iber J., et al. Update on vaccine-derived polioviruses-worldwide, January 2016-June 2017. MMWR. Morbidity and Mortality Weekly Report . 2017;66(43):1185–1191. doi: 10.15585/mmwr.mm6643a6.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6643a6</ArticleId><ArticleId IdType="pmc">PMC5689216</ArticleId><ArticleId IdType="pubmed">29095803</ArticleId></ArticleIdList></Reference><Reference><Citation>Tebbens R. J. D., Thompson K. M. Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine. Expert Review of Vaccines . 2018;17(8):739–751. doi: 10.1080/14760584.2018.1506333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2018.1506333</ArticleId><ArticleId IdType="pmc">PMC6168953</ArticleId><ArticleId IdType="pubmed">30056767</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>